IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q1 2025 Holdings

Filed 2025-05-15 | 68 holdings | $115.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
EQT Corporation(EQT)COM26884L109$1.8M34,6191.6%
Masimo Corp(MASI)COM574795100$1.9M11,2801.6%
Harrow Health Inc(HROW)COM415858109$1.9M72,9101.7%
Ovintiv Inc(OVV)COM69047Q102$2.2M52,2001.9%
Docgo Inc(DCGO)COM256086109$2.3M864,0622.0%
United Therapeutics Corp(UTHR)COM91307C102$2.3M7,5002.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$2.3M48,0022.0%
Quidelortho CorpCOM74838J101$2.4M67,6192.1%
Travere Therapeutics Inc(TVTX)COM89422G107$2.5M138,0002.1%
Phreesia Inc(PHR)COM71944F106$2.9M114,7002.5%
Axogen Inc(AXGN)COM05463X106$3.0M161,0002.6%
Elutia Inc(ELUT)COM05479K106$3.0M1,187,7352.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$3.3M30,2402.9%
Biodesix IncCOM09075X108$3.6M5,736,1133.1%
Prothena Corp PLC(PRTA)SHSG72800108$4.1M332,9743.6%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$4.4M263,4003.8%
Corcept Therapeutics Inc(CORT)COM218352102$7.5M66,0006.5%
Bristol-Myers Squibb Co(BMY)COM110122108$41.8M685,19236.3%
PreviousPage 2 of 2